Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.259, 2000-01, pp. : 3-3
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Benefits with incretin-targeted therapies in T2DM
Inpharma, Vol. 1, Iss. 1596, 2007-01 ,pp. :
Persistent drug use provide economic benefits in DM
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 579, 2009-01 ,pp. :
Health Benefits from Eating Fish
Comments® on Toxicology, Vol. 8, Iss. 4-6, 2002-07 ,pp. :
No benefits from levothyroxine dosage changes
Inpharma, Vol. 1, Iss. 1554, 2006-01 ,pp. :